📰 Aezs News
Page 2 - Aezs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aezs. Real-time updates on events, politics, business and more.
January 28, 2024
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright decreased their target price on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating […]
January 12, 2024
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reduced their target price on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the […]
January 5, 2024
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reduced their price objective on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the company […]
January 4, 2024
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price target on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the […]
December 28, 2023
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright dropped their target price on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the […]
December 28, 2023
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price objective on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the stock in […]
December 20, 2023
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright cut their price target on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the company in […]
December 12, 2023
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright dropped their target price on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the stock […]
November 18, 2023
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price target on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the stock in a […]
November 9, 2023
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 price target on shares of Aeterna Zentaris in a report […]